Infinity Pharmaceuticals (INFI)
2.24
+0.04 +1.82%
NASDAQ
Apr 20, 20:00
Delayed 2m
USD
View All Key Stats
INFI Key Stats
| Income Statement | |
| Revenue (TTM) | -- |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -0.84 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -41.83M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -- |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 116.39M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | -- |
| PE Ratio (TTM) | -- |
| Price to Book Value | 2.439 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | 1.191M |
| Return on Equity (TTM) | Upgrade |
View All INFI News
INFI News
-
WireHeadlineTime (ET)
-
Yahoo04/16 03:06
-
Yahoo04/12 09:38
-
Yahoo04/11 11:56
-
Yahoo03/28 08:41
-
PR Newswire03/26 08:32
-
Yahoo03/22 05:54
-
PR Newswire03/21 11:36
-
Yahoo03/16 18:36
-
Yahoo03/16 17:16
-
SA Breaking News03/16 11:02
View All Events
INFI Events
| Date | Type | Description |
|---|---|---|
| 05/09/2018 | Misc | Infinity Pharmaceuticals Inc First Quarter Earnings Conference Call in 2018 |
| 05/09/2018 | Earnings | Infinity Pharmaceuticals Inc First Quarter Earnings Results in 2018 |
| 03/15/2018 16:30 EST | Misc | Infinity Pharmaceuticals Inc Fourth Quarter Earnings Conference Call in 2017 |
| 03/15/2018 | Earnings | Infinity Pharmaceuticals Inc Fourth Quarter Earnings Results in 2017 |
| 03/15/2018 | Misc | Infinity Pharmaceuticals Inc Annual Report in 2017 |
| 11/10/2017 | Misc | Infinity Pharmaceuticals Inc Third Quarter Earnings Results in 2017 |
| 11/07/2017 | Earnings | Infinity Pharmaceuticals Inc Third Quarter Earnings in 2017 Release |
| 11/07/2017 08:30 EDT | Misc | Infinity Pharmaceuticals Inc Third Quarter Earnings Conference Call in 2017 |
| 08/03/2017 16:30 EDT | Misc | Infinity Pharmaceuticals Inc Second Quarter Earnings Conference Call in 2017 |
| 08/03/2017 | Earnings | Infinity Pharmaceuticals Inc Second Quarter Earnings in 2017 Release |
INFI Fundamentals
Income Statement View Statement
INFI Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
INFI One Page Reports
- One Page Report Download
INFI Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 2.24 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.infi.com
- Investor Relations URL: http://phx.corporate-ir.net/phoenix.zhtml?c=121941&p=irol-irhome
- HQ State/Province: Massachusetts
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Value
- Next Earnings Release: May. 09, 2018
- Last Earnings Release: Mar. 15, 2018
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Infinity Pharmaceuticals Inc is a biopharmaceutical company focused on developing novel medicines for the treatment of specific cancers. It is focused on advancing IPI-549, an orally administered, clinical-stage, immuno-oncology product candidate.
INFI Excel Add-In Codes
- Name: =YCI("INFI","name")
- Description: =YCI("INFI","description")
- Sector: =YCI("INFI","sector")
- Industry: =YCI("INFI","industry")
- Est. Current Fiscal Year End: =YCI("INFI","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other INFI Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- INFI Tweets Stocktwits
Advertisement
